Herceptin Obs Cancer BPL 06 2013 - Divorce


PDF
Videos
List Docs
  • When should I take Herceptin for early stage cancer?

    It’s more likely that you’ll take Herceptin for an early stage cancer if your tumor is larger or has spread to lymph nodes. Your doctor also might suggest it if there’s reason to think your cancer will grow faster or come back. Herceptin can help to keep early stage HER2-positive cancer from coming back after surgery.

  • Is Herceptin the 'drug that changed the breast cancer treatment landscape?

    Deemed as the “drug that changed the breast cancer treatment landscape,” Herceptin has saved millions of women’s lives by targeting cancer at its genetic roots. In this interview, Dr. Slamon talks about the paradigm-shifting approach to cancer treatment and how the discovery has opened up an entirely new area of research.

  • Does Herceptin work on HER2?

    If tests show your cancer can’t be removed with surgery, Herceptin and other treatments may help shrink it enough to make surgery possible. If your HER2-positive breast cancer has spread to distant parts of your body, Herceptin can help to stop or slow its growth. Herceptin isn’t the only treatment for breast cancer that works on HER2.

Herceptin

Herceptin

Dr. Sramila Aithal Describes the HERceptin Adjuvant (HERA) Trial for HER2-Positive Breast Cancer

Dr. Sramila Aithal Describes the HERceptin Adjuvant (HERA) Trial for HER2-Positive Breast Cancer

Herceptin signaling pathway  Trastuzumab

Herceptin signaling pathway Trastuzumab

Share on Facebook Share on Whatsapp











Choose PDF
More..











HERCEPTIN Sous-Cutanée - OMEDIT Pays de la Loire - Divorce herche cument « Le M s, en pr docum de la sé ns l`apr nt à Herchenrode Hessische Meisterschaften Vierspänner Pferde/Ponys Herco Wassertechnik GmbH - Freiberger Unternehmerforum Hercule HERCULE - Secobra Recherche Hercule des Chtis Loves Hercule et Cacus, étude de mythologie comparée - Linux

PDFprof.com Search Engine
Images may be subject to copyright Report CopyRight Claim

PDF) Trastuzumab therapy in breast cancer: To reload or not to reload?

PDF) Trastuzumab therapy in breast cancer: To reload or not to reload?


PDF) Safety and tolerability of subcutaneous trastuzumab for the

PDF) Safety and tolerability of subcutaneous trastuzumab for the


PDF) Subcutaneous administration of rituximab (MabThera) and

PDF) Subcutaneous administration of rituximab (MabThera) and


Long-term outcome data for patients with HER2- positive early

Long-term outcome data for patients with HER2- positive early


PDF) Overcoming trastuzumab resistance in HER2‐positive breast

PDF) Overcoming trastuzumab resistance in HER2‐positive breast


Long-term outcome data for patients with HER2- positive early

Long-term outcome data for patients with HER2- positive early


Factors associated with treatment delay in women with primary

Factors associated with treatment delay in women with primary


PDF) Neratinib overcomes trastuzumab resistance in HER2 amplified

PDF) Neratinib overcomes trastuzumab resistance in HER2 amplified


Long-term outcome data for patients with HER2- positive early

Long-term outcome data for patients with HER2- positive early


PDF) Expression Enhancement in Trastuzumab Therapeutic Monoclonal

PDF) Expression Enhancement in Trastuzumab Therapeutic Monoclonal


Long-term outcome data for patients with HER2- positive early

Long-term outcome data for patients with HER2- positive early


Nomogram for predicting cancer specific survival in inflammatory

Nomogram for predicting cancer specific survival in inflammatory


PDF) Real-World Data on Health-Related Quality of Life Assessment

PDF) Real-World Data on Health-Related Quality of Life Assessment


The effects of an integrated supportive care intervention on

The effects of an integrated supportive care intervention on


Nomogram for predicting cancer specific survival in inflammatory

Nomogram for predicting cancer specific survival in inflammatory


PDF) Predictors of Fatigue in Cancer Patients Before and After

PDF) Predictors of Fatigue in Cancer Patients Before and After


Randomized‐controlled trial of mindfulness‐based cancer recovery

Randomized‐controlled trial of mindfulness‐based cancer recovery


Trastuzumab-associated cardiac events in the Persephone trial

Trastuzumab-associated cardiac events in the Persephone trial


PDF) Estimation of the cost of treatment by chemotherapy for early

PDF) Estimation of the cost of treatment by chemotherapy for early


6 versus 12 months of adjuvant trastuzumab for HER2-positive early

6 versus 12 months of adjuvant trastuzumab for HER2-positive early


Physical activity in long-term breast cancer survivors – A mixed

Physical activity in long-term breast cancer survivors – A mixed


Three-year follow-up from a phase 3 study of SB3 (a trastuzumab

Three-year follow-up from a phase 3 study of SB3 (a trastuzumab


Radiotherapy after mastectomy has significant survival benefits

Radiotherapy after mastectomy has significant survival benefits


PDF) Socioeconomic factors affecting trastuzumab usage in patients

PDF) Socioeconomic factors affecting trastuzumab usage in patients


Patient-reported Outcomes of Patients With Breast Cancer During

Patient-reported Outcomes of Patients With Breast Cancer During


Herceptin Therapy for Breast Cancer

Herceptin Therapy for Breast Cancer


Would 10 cm be a more suitable cutoff to subdivide pT1 tumors in

Would 10 cm be a more suitable cutoff to subdivide pT1 tumors in


PDF) An update on the management of breast cancer in Africa

PDF) An update on the management of breast cancer in Africa


SHP-1 reverses trastuzumab resistance and migration in HER2

SHP-1 reverses trastuzumab resistance and migration in HER2


Efficacy of short-term psychodynamic psychotherapy (STPP) with

Efficacy of short-term psychodynamic psychotherapy (STPP) with


PDF) Bedtime misalignment and progression of breast cancer

PDF) Bedtime misalignment and progression of breast cancer


Roche - FDA approves Herceptin Hylecta for subcutaneous injection

Roche - FDA approves Herceptin Hylecta for subcutaneous injection


The Impact of Radiodermatitis on Breast Cancer Patients' Quality

The Impact of Radiodermatitis on Breast Cancer Patients' Quality


Guideline-Concordant Treatment Among Elderly Women With HER2

Guideline-Concordant Treatment Among Elderly Women With HER2


Early breast cancer: ESMO Clinical Practice Guidelines for

Early breast cancer: ESMO Clinical Practice Guidelines for


Black-White Disparities in Breast Cancer Subtype: The Intersection

Black-White Disparities in Breast Cancer Subtype: The Intersection


Responding to the challenge of cancer in Europe - European Public

Responding to the challenge of cancer in Europe - European Public


Pembrolizumab plus trastuzumab in trastuzumab-resistant  advanced

Pembrolizumab plus trastuzumab in trastuzumab-resistant advanced


The influence of gene expression profiling on decisional conflict

The influence of gene expression profiling on decisional conflict


Adherence of Mexican physicians to clinical guidelines in the

Adherence of Mexican physicians to clinical guidelines in the


SHP-1 reverses trastuzumab resistance and migration in HER2

SHP-1 reverses trastuzumab resistance and migration in HER2


Short-duration versus 1-year adjuvant trastuzumab in early HER2

Short-duration versus 1-year adjuvant trastuzumab in early HER2


https://wwwvalueinhealthjournalcom/article/S1098-3015(19)30048-8/fulltext

https://wwwvalueinhealthjournalcom/article/S1098-3015(19)30048-8/fulltext


Safety profile of subcutaneous trastuzumab in patients with HER2

Safety profile of subcutaneous trastuzumab in patients with HER2


PDF) Effectiveness of a patient self-management programme for

PDF) Effectiveness of a patient self-management programme for

Politique de confidentialité -Privacy policy